Medicinal Chemistry Research

, Volume 23, Issue 5, pp 2426–2438 | Cite as

Synthesis and anticancer activity evaluation of new 1,2,3-triazole-4-carboxamide derivatives

  • Nazariy Pokhodylo
  • Olga Shyyka
  • Vasyl Matiychuk
Original Research


Anticancer screening of several novel 1,2,3-triazoles has been performed. The 1,2,3-triazole derivatives were synthesized from available starting materials according to the convenient synthetic procedures using a multicomponent reaction which gave a wide access to triazole derivatives production. The synthesized compounds were tested for their anticancer activity in NCI60 cell lines. It was observed that some compounds showed remarkable anticancer activity. Two of them possessed a significant activity on leukemia, melanoma, non-small cell lung, CNS, ovarian, renal, and breast cancer. 5-Amino-1-p-tolyl-1H-[1,2,3]triazole-4-carboxylic acid (2,5-dichloro-phenyl)-amide showed a significant correlation in COMPARE analysis.

Graphical Abstract

1,2,3-triazole-4-carboxamide derivatives were synthesized in a simple and convenient synthetic path, their in vitro anticancer activity was examined after the performance of molecular docking.


Anticancer activity 1,2,3-Triazole-4-carboxamide COMPARE analysis Molecular docking 



The authors are grateful to Dr. V. L. Narayanan from the Drug Synthesis and Chemistry Branch, the National Cancer Institute, Bethesda, MD, USA, for his help in in vitro evaluation of anticancer activity.

Conflict of interest

The authors have declared no conflict of interest.


  1. Alvarez R, Velazquez S, San-Felix A, Aquaro S, De Clercq E, Perno CF, Karlsson A, Balzarini J, Camarasa MJ (1994) 1,2,3-Triazole-[2,5-Bis-O-(tert-butyldimethylsilyl)-.beta.-D-ribofuranosyl]-3’-spiro-5″-(4″-amino-1″,2″-oxathiole 2″,2″-dioxide) (TSAO) Analogs: synthesis and Anti-HIV-1 Activity. J Med Chem 37:4185–4194CrossRefPubMedGoogle Scholar
  2. Bascal Z, Holden-Dye L, Willis RJ, Smith SWG, Walker RJ (1996) Novel azole derivatives are antagonists at the inhibitory. GABA receptor on the somatic muscle cells of the parasitic nematode Ascaris suum. Parasitology 112:253–269CrossRefPubMedGoogle Scholar
  3. Biagi G, Giorgi I, Livi O, Lucacchini A, Martini C, Scartoni V (1993) Studies on specific inhibition of benzodiazepine receptor binding by some C-benzoyl-1,2,3-triazole derivatives. J Pharm Sci 82:893–896CrossRefPubMedGoogle Scholar
  4. Bohm R, Karow C (1981) Biologically active triazoles. Pharmazie 36:243–247PubMedGoogle Scholar
  5. Boyd MR (1997) In: Teicher BA (ed) Cancer Drug Discovery and Development, vol 2. Humana Press, Totowa, pp 23–43Google Scholar
  6. Boyd MR, Paull KD (1995) Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen. Drug Dev Res 34:91–109CrossRefGoogle Scholar
  7. Buckle DR, Rockell CJM, Smith H, Spicer BA (1986) Studies on 1,2,3-triazoles. 13. (Piperazinylalkoxy)-[1]benzopyrano[2,3-d]-1,2,3-triazol-9(1H)-ones with combined H1-antihistamine and mast cell stabilizing properties. J Med Chem 29:2262–2267CrossRefPubMedGoogle Scholar
  8. Chakrabarti JK, Hotten TM, Pullar IA, Steggles DJ (1989) Heteroarenobenzodiazepines. 6. Synthesis and pharmacological evaluation of CNS activities of [1,2,3]triazolo[4,5-b][1,5]-, imidazolo[4,5,-b][1,5]-, and pyrido[2,3-b][1,5]benzodiazepines. 10-Piperazinyl-4H-1,2,3-triazolo[4,5-b][1,5]benzodiazepines with neuroleptic activity. J Med Chem 32:2375–2381CrossRefPubMedGoogle Scholar
  9. Ciardiello F, Tortora G (2008) Drug Therapy: EGFR Antagonists in Cancer Treatment. N Eng J Med 358:1160–1174CrossRefGoogle Scholar
  10. Fass RJ, Prior RB (1978) Comparative activities of oral cephalosporins and competitive antibiotics against recent clinical isolates. Curr Ther Res 24:352–365Google Scholar
  11. Accessed 17 Oct 2013
  12. Hupe DJ, Boltz R, Cohen CJ, Felix J, Ham E, Miller D, Soderman D, Van Skiver D (1991) The inhibition of receptor-mediated and voltage-dependent calcium entry by the antiproliferative L-651,582. J Biol Chem 266:10136–10142PubMedGoogle Scholar
  13. Moltzen EK, Pedersen H, Bogeso KP, Meier E, Frederiksen K, Sanchez C, Lembol KL (1994) Bioisosteres of arecoline: 1,2,3,6-tetrahydro-5-pyridyl-substituted and 3-piperidyl-substituted derivatives of tetrazoles and 1,2,3-triazoles. Synthesis and muscarinic activity. J Med Chem 37:4085–4099CrossRefPubMedGoogle Scholar
  14. Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A, Gray-Goodrich M, Campbell H, Mayo J, Boyd M (1991) Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Nat Cancer Inst 83:757–766CrossRefPubMedGoogle Scholar
  15. Obushak ND, Matiichuk VS, Vasylyshin RYA, Ostapyuk YUV (2004) Heterocyclic syntheses on the basis of arylation products of unsaturated compounds: X. 3-Aryl-2-chloropropanals as reagents for the synthesis of 2-amino-1,3-thiazole derivatives. Russ J Org Chem 40:383–389CrossRefGoogle Scholar
  16. Olesen PH, Sorensen AR, Urso B, Kurtzhals P, Bowler AN, Ehrbar U, Hansen BF (2003) Synthesis and in vitro characterization of 1-(4-aminofurazan-3-yl)-5-dialkylaminomethyl-1H-[1,2,3]triazole-4-carboxylic acid derivatives. A New Class of Selective GSK-3 Inhibitors. J Med Chem 46:3333–3341CrossRefPubMedGoogle Scholar
  17. Pao W, Chmielecki J (2010) Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer 10:760PubMedCentralCrossRefPubMedGoogle Scholar
  18. Paull KD, Shoemaker RH, Hodes L, Monks A, Scudiero DA, Rubinstein L, Plowman J, Boyd MR (1989) Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J Nat Cancer Inst 81:1088–1092CrossRefPubMedGoogle Scholar
  19. Pokhodylo NT, Matiychuk VS, Obushak MD (2009a) One-pot multicomponent synthesis of 1-aryl-5-methyl-N-R2-1H-1,2,3-triazole-4-carboxamides: an easy procedure for combinatorial chemistry. J Comb Chem 11:481–485CrossRefPubMedGoogle Scholar
  20. Pokhodylo NT, Matiychuk VS, Obushak MD (2009b) Synthesis of triazoles via regioselective reactions of aryl azides with cyanoacetyl pyrroles and indoles. Synthesis 8:1297–1300Google Scholar
  21. Pokhodylo NT, Teslenko YO, Matiychuk VS, Obushak MD (2009c) Synthesis of 2,1-benzisoxazoles by nucleophilic substitution of hydrogen in nitroarenes activated by the azole ring. Synthesis 17:2741–2748CrossRefGoogle Scholar
  22. Portmann R, Hofmeier UC, Burkhard A, Scherrer W, Szelagiewicz M (1998) Crystal modification of 1-(2,6-difluorobenzyl)- 1H-1,2,3-triazole-4-carboxamide and its use as antiepileptic. number WO/1998/056772Google Scholar
  23. Sanghvi YS, Bhattacharya BK, Kini GD, Matsumoto SS, Larson SB, Jolley WB, Robins RK, Revankar GR (1990) Growth inhibition and induction of cellular differentiation of human myeloid leukemia cells in culture by carbamoyl congeners of ribavirin. J Med Chem 33:336–344CrossRefPubMedGoogle Scholar
  24. Shoemaker RH (2006) The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 6:813–823CrossRefPubMedGoogle Scholar
  25. Weinstein JN, Myers TG, O’Connor PM, Friend SH, Fornace AJ, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL (1997) An information-intensive approach to the molecular pharmacology of cancer. Science 275:343–349CrossRefPubMedGoogle Scholar
  26. Zaharevitz DW, Holbeck SL, Bowerman C, Svetlik PA (2002) COMPARE: a web accessible tool for investigating mechanisms of cell growth inhibition. J Mol Graph Model 20:297–303CrossRefPubMedGoogle Scholar
  27. Zhang H, Berezov A, Wang Q, Zhang G, Drebin J, Murali R, Greene MI (2007) ErbB receptors: from oncogenes to targeted cancer therapies. J Clin Invest 117:2051–2058PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Nazariy Pokhodylo
    • 1
  • Olga Shyyka
    • 1
  • Vasyl Matiychuk
    • 1
  1. 1.Organic Chemistry DepartmentIvan Franko National University of LvivLvivUkraine

Personalised recommendations